OpenCapital
Earnings
Stock Screener
Metrics
/
Stocks
Connect AI
Toggle navigation menu
Stocks
Moderna
Balance Sheet Statement
Research and development funding receivable (Note 5)
Other
Research and development funding receivable (Note 5)
Export Chart
Analysis
Statement
Balance Sheet Statement
Section
Other
First reported
Q4 2024
Last reported
Q1 2026
May 1, 2026
Metric ID:
other_grant_receivable_research_and_development_current
Historical Data
5 periods
Quarterly
Annual
TTM
Q4 '24
Q2 '25
Q3 '25
Q4 '25
Q1 '26
Value
$0.00
$191.00M
$195.00M
$0.00
$7.00M
QoQ Change
—
—
+2.1%
-100.0%
—
Range
$0.00 – $195.00M
Frequently Asked Questions
What is Moderna's research and development funding receivable (note 5)?
Moderna (MRNA) reported research and development funding receivable (note 5) of $7.00M in Q1 2026.